norharman has been researched along with vasicine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Hua, HM; Jing, YK; Li, DH; Li, SG; Lin, B; Wang, KB; Wang, YT; Xue, JJ; Zhang, Q | 1 |
2 other study(ies) available for norharman and vasicine
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Pegaharmols A-B, Axially Chiral β-Carboline-quinazoline Dimers from the Roots of
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Carbolines; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Molecular Structure; Peganum; Plant Extracts; Plant Roots; Quinazolines | 2020 |